Makes implantable lenses that replace glasses or contacts for vision correction, plus tools eye surgeons use during cataract procedures. Think of it as a tiny, permanent contact lens surgically placed inside the eye.
Sells lenses and surgical injectors to eye doctors and distributors worldwide. Revenue is roughly USD 0.24B annually, with gross margins around 76%, but recent operating losses (USD -0.05B) show it's not yet consistently profitable—money comes from repeat surg
Strong brand recognition among ophthalmologists for its Collamer lens material, which competitors like Alcon and Johnson & Johnson haven't matched in the implantable lens niche. However, regulatory approvals and pricing pressure in key markets like China could
